TYRA: RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M. discloses a purchase
By AlphaYouPublished Form 4
RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M.
Reporting filer
RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M. reported Purchase in Tyra Biosciences, Inc.: 9078529 units of Pre-Funded Warrants (Right to Buy) (derivative), dated 2026-09-15. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 17, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Pre-Funded Warrants (Right to Buy) (derivative) | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M. | 2026-09-15 | P | Purchase | 9078529 | 22.029 | 11,616,986 | 2 days | Filed terms
|
Pre-Funded Warrants (Right to Buy) (derivative)
- Owner
- RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M.
- Date
- 2026-09-15
- Code
- P
- Action
- Purchase
- Quantity
- 9078529
- Price
- 22.029
- Following holdings
- 11,616,986
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Pre-Funded Warrants (Right to Buy)
- conversion Or Exercise Price: 0.001
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Shares: 9078529
- transaction Price Per Share: 22.029
- transaction Acquired Disposed Code: A
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 9078529
- shares Owned Following Transaction: 11616986
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F2
- id: F3
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- RA CAPITAL MANAGEMENT, L.P.: Director, 10% owner.
- RA Capital Healthcare Fund LP: Director, 10% owner.
- RA Capital Nexus Fund, L.P.: Director.
- Kolchinsky Peter: Director, 10% owner.
- Shah Rajeev M.: Director, 10% owner.
- F1: The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrants to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Persons, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 19.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.
- F2: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
- F3: Held directly by the Fund.
Original sources
Prepared automatically from public filing data. Report a correction.